Talar W Markossian1, Elizabeth A Calhoun. 1. Health Policy and Management, Georgia Southern University, Jiann-Ping Hsu College of Public Health, P.O. Box 8015, Statesboro, GA 30460-8015, United States. tmarkossian@georgiasouthern.edu
Abstract
OBJECTIVES: One of the aims of the Chicago Cancer Navigation Project (CCNP) is to reduce the interval of time between abnormal breast cancer screening and definitive diagnosis in patients who are navigated as compared to usual care. In this article, we investigate the extent to which total costs of breast cancer navigation can be offset by survival benefits and savings in lifetime breast cancer-attributable costs. METHODS: Data sources for the cost-effectiveness analysis include data from published literature, secondary data from the NCI's Surveillance Epidemiology and End Results (SEER) program, and primary data from the CCNP. RESULTS: If women enrolled in CCNP receive breast cancer diagnosis earlier by 6 months as compared to usual care, then navigation is borderline cost-effective for $95,625 per life-year saved. Results from sensitivity analyses suggest that the cost-effectiveness of navigation is sensitive to: the interval of time between screening and diagnosis, percent increase in number of women who receive cancer diagnosis and treatment, women's age, and the positive predictive value of a mammogram. CONCLUSIONS: In planning cost-effective navigation programs, special considerations should be made regarding the characteristics of the disease, program participants, and the initial screening test that determines program eligibility.
OBJECTIVES: One of the aims of the Chicago Cancer Navigation Project (CCNP) is to reduce the interval of time between abnormal breast cancer screening and definitive diagnosis in patients who are navigated as compared to usual care. In this article, we investigate the extent to which total costs of breast cancer navigation can be offset by survival benefits and savings in lifetime breast cancer-attributable costs. METHODS: Data sources for the cost-effectiveness analysis include data from published literature, secondary data from the NCI's Surveillance Epidemiology and End Results (SEER) program, and primary data from the CCNP. RESULTS: If women enrolled in CCNP receive breast cancer diagnosis earlier by 6 months as compared to usual care, then navigation is borderline cost-effective for $95,625 per life-year saved. Results from sensitivity analyses suggest that the cost-effectiveness of navigation is sensitive to: the interval of time between screening and diagnosis, percent increase in number of women who receive cancer diagnosis and treatment, women's age, and the positive predictive value of a mammogram. CONCLUSIONS: In planning cost-effective navigation programs, special considerations should be made regarding the characteristics of the disease, program participants, and the initial screening test that determines program eligibility.
Authors: Jon F Kerner; Michael Yedidia; Deborah Padgett; Barbara Muth; Kathleen Shakira Washington; Mariella Tefft; K Robin Yabroff; Erini Makariou; Harold Freeman; Jeanne S Mandelblatt Journal: Prev Med Date: 2003-08 Impact factor: 4.018
Authors: Jeanne S Mandelblatt; Clyde B Schechter; K Robin Yabroff; William Lawrence; James Dignam; Peter Muennig; Yoko Chavez; Jennifer Cullen; Marianne Fahs Journal: J Clin Oncol Date: 2004-06-01 Impact factor: 44.544
Authors: K Robin Yabroff; Nancy Breen; Sally W Vernon; Helen I Meissner; Andrew N Freedman; Rachel Ballard-Barbash Journal: Cancer Epidemiol Biomarkers Prev Date: 2004-05 Impact factor: 4.254
Authors: Anne Elizabeth Glassgow; Yamile Molina; Sage Kim; Richard T Campbell; Julie Darnell; Elizabeth A Calhoun Journal: Health Promot Pract Date: 2018-06-15
Authors: Jessie Kimbrough Marshall; Olive M Mbah; Jean G Ford; Darcy Phelan-Emrick; Saifuddin Ahmed; Lee Bone; Jennifer Wenzel; Gary R Shapiro; Mollie Howerton; Lawrence Johnson; Qiana Brown; Altovise Ewing; Craig Evan Pollack Journal: J Gen Intern Med Date: 2015-08-11 Impact factor: 5.128
Authors: Mark E Bensink; Scott D Ramsey; Tracy Battaglia; Kevin Fiscella; Thelma C Hurd; June M McKoy; Steven R Patierno; Peter C Raich; Eric E Seiber; Victoria Warren-Mears; Elizabeth Whitley; Electra D Paskett; S Mandelblatt Journal: Cancer Date: 2013-10-25 Impact factor: 6.860
Authors: Rahel G Ghebre; Lovell A Jones; Jennifer A Wenzel; Michelle Y Martin; Raegan W Durant; Jean G Ford Journal: Cancer Date: 2014-04-01 Impact factor: 6.860
Authors: Beti Thompson; Sarah D Hohl; Yamile Molina; Electra D Paskett; James L Fisher; Ryan D Baltic; Chasity M Washington Journal: Curr Breast Cancer Rep Date: 2018-08-29